UnitedHealth Group Incorporated (UNH)
UnitedHealth Group: The 2025 Investment Thesis
UnitedHealth Group is positioned as a leader in the health services industry despite setbacks from a cyberattack and industry headwinds in 2024. The company's 2025 investment thesis is optimistic, with expectations of market share gains, margin improvements, and recovery for Optum Insight. UNH is expected to outperform in 2025, with the potential for revenue growth above estimates, leading to a price target of $640 per share.
UnitedHealth Group: Now Is The Time To Buy This Dividend Compounder
UnitedHealth Group has markedly outperformed the S&P 500 since my last buy rating. The managed care company's revenue and adjusted diluted EPS climbed in the second quarter. UnitedHealth Group enjoys an A+ credit rating from S&P.
Is Trending Stock UnitedHealth Group Incorporated (UNH) a Buy Now?
Recently, Zacks.com users have been paying close attention to UnitedHealth (UNH). This makes it worthwhile to examine what the stock has in store.
Earnings Growth & Price Strength Make UnitedHealth Group (UNH) a Stock to Watch
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
UnitedHealth (UNH) Q2 Success: A Turnaround Worth Investing in?
UnitedHealth (UNH) is navigating its challenges effectively, maintaining a positive outlook for the future while demonstrating a strong commitment to its clients and shareholders.
Here's Why UnitedHealth Group (UNH) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to UnitedHealth (UNH). This makes it worthwhile to examine what the stock has in store.
Why UnitedHealth Group (UNH) is a Top Stock for the Long-Term
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
UnitedHealth Group Rallies Despite Continued Cyberattack Cost Pressures. Is It Too Late to Buy the Stock?
UnitedHealth Group shares rallied despite the continued effect of a cyberattack and medical care ratio pressures. However, the worst appears to be behind the company.
Should You Pick UnitedHealth Stock At $575 After A Q2 Beat?
UnitedHealth Group (NYSE: UNH) recently reported its Q2 results, with revenues slightly below and earnings exceeding our expectations. The company reported revenue of $98.6 billion and adjusted earnings of $6.80 per share, compared to our estimates of $99 billion and $6.75, respectively.
UnitedHealth Rises on Q2 Earnings Beat: ETFs to Gain
UnitedHealth Group (UNH) reported better-than-expected second-quarter 2024 results as it breezed past the Zacks Consensus Estimate on both earnings and revenues.
As UnitedHealth's stock heads toward record high, bonds are selling off and spreads are wider
As UnitedHealth Group Inc.'s stock headed toward a record high on Wednesday, the company's bonds have been selling off following the company's quarterly earnings report early Tuesday.
